DermaSensor, Inc.

We’re honored to share that DermaSensor has been named “Best in Class – Clinical Diagnostic Device” at the 2025 The Digital Health Hub Foundation - Digital Health Awards at HLTH USA. 🏆 This award recognizes real-world innovation in healthcare, and we’re proud to support primary care with real-time, non-invasive skin cancer detection, alongside an inspiring group of digital health leaders. From AI in health operations and patient care to advancements in women’s health, mental health, oral care, home diagnostics, and beyond — the winners and rising stars in this year’s awards represent the future of healthcare. Congratulations to our fellow honorees including Cohere Health, Etiometry Inc., OraQ AI, TailorMed, OMRON Healthcare, Inc., Imagine Pediatrics, Spring Health, Hello Heart, Future Family, and all the incredible rising stars driving meaningful change across the industry. We're grateful to be part of this inspiring community and excited for what’s ahead in the future of care. #HLTH2025 #DigitalHealthAwards #DermaSensor #InnovationInCare #PrimaryCare #SkinCancerDetection #HealthTech

We’re excited to be part of HLTH USA 2025 in Las Vegas! Come meet us at the Startup Health Pavilion – Booth # 1760-11 and discover how DermaSensor’s AI-powered device is changing the future of skin cancer detection. Let's connect! 🤝 #HLTHUSA #SkinCancer #SkinHealth #MedTech #BeBold  #SkinCancerAssessment #Physician #Healthcare #HealthInnovation #FutureOfHealth

Evaluating suspicious skin lesions remains a challenge — visual exams are subjective, and dermatology training varies widely among clinicians. DermaSensor is addressing this challenge with its FDA-cleared, AI-powered spectroscopy device that provides fast, objective insights to assess skin cancer risk and support clinical decision-making in real time.  👉 Learn how DermaSensor is advising skin cancer detection, visit: https://lnkd.in/eQrESi3t . #DermaSensor #medtech #skincancerprevention #healthtech #medicaldevices 

What a great week at #FMX2025! 🙌 The excitement and positive feedback we received were incredible. It’s clear that DermaSensor is helping primary care providers bring skin cancer detection directly into their offices. A special thank you to Dr. Nate Falk, MD, MBA, CPE, FAAFP, for joining our team and sharing his first-hand experience using DermaSensor in practice - and to all the attendees who stopped by and made this such a great event. Until next year, FMX! 👋 To learn more about our technology and reimbursement options, visit: https://lnkd.in/gFu22rrF #FMX2025 #PrimaryCare #SkinCancerDetection #AIinHealthcare #MedicalInnovation #DermaSensor

This week, Cody Simmons represented our team at The MedTech Conference in San Diego, hosted by AdvaMed. During the panel “Navigating the FDA’s De Novo Program: Incorporating Best Practices from the Beginning,” he joined fellow medtech leaders to exchange insights on innovation and best practices in bringing breakthrough technologies to patients. This year’s conference celebrated AdvaMed’s 50th anniversary, bringing together thousands of attendees and companies from around the world to explore how medtech continues to shape the future of healthcare. We appreciate the opportunity to take part in these conversations that foster collaboration and drive innovation across the industry! 👉 To learn more about our technology, visit www.dermasensor.com #AdvaMed2025 #MedTech #Innovation #AI #Healthcare #MedicalDevices #DermaSensor

👋 Heading to FMX 2025? Stop by booth #1203 to meet Nate Falk, MD, MBA, CPE, FAAFP a DermaSensor user who has integrated our FDA-cleared, AI-powered technology into his clinical practice. Dr. Falk will be joining our commercial team to share his first-hand experience and answer your questions about how DermaSensor supports skin cancer detection at the point of care. Come say hello — and see the technology in action! #AAFPFMX2025 #DermaSensor #AIinHealthcare #PrimaryCare #Innovation

It’s FMX time. 🎉 We are looking forward to connecting with family physicians and care teams at #AAFPFMX in Anaheim this week, where leaders in primary care come together to exchange insights and shape the future of family medicine. Visit us at Booth #1203 to explore how DermaSensor’s FDA-cleared, AI-powered technology supports physicians in assessing skin cancer risk right at the point of care. 👉 Together, we’re advancing innovation in primary care. #AAFPFMX #FamilyMedicine #AIinHealthcare #MedTech #DermaSesnor

🚀 Big news from DermaSensor! We’ve raised $16 million in Series B funding, bringing our total to $43 million — fueling the expansion of our FDA cleared, handheld skin cancer detection device. Since launching in mid-2024, we've surpassed 20,000 lesions scanned with an incredible 117% quarterly growth rate, helping frontline physicians detect cancer earlier and more accurately. Featured in publications like Nature and media outlets like TIME’s Best Inventions of 2024, our AI-powered optical spectroscopy device is the first and only of its kind approved for primary care use in the U.S. We're proud to be transforming skin cancer detection and excited for what’s next. Thank you to our investors — including Pier 70 Ventures, Kern Venture Group, GenHenn Capital, and more — for believing in our mission. Read more: https://lnkd.in/gWC9mCip #SkinCancerAwareness #HealthTech #FDAcleared #AIinHealthcare #DigitalHealth #PrimaryCare #SeriesB #MedTech #Innovation #DermaSensor

💯 Grateful to sponsor this year’s Private Physicians Alliance Annual Meeting 2025! DermaSensor joined this exclusive community of concierge physicians to share how our FDA-cleared, AI-powered device supports skin cancer risk assessments right at the point of care. A special thank you to Dr. Brian Hollett, MD, MBA from Chicago-based SHIFT for leading an engaging session, where he presented how skin cancer detection with DermaSensor is seamlessly integrated into his clinical workflow, empowering concierge physicians with real-time, data-driven insights to better serve their patients. Great conversations, inspiring peers, and a shared commitment to advancing personalized healthcare. We’re grateful to have connected with so many leaders shaping the future of medicine at PPA 2025! #PPAHealth #SHIFT #DermaSensor #HealthTech #Innovation #MedicalDevices #SkinCancerAwareness

🌟 Proud Moment for DermaSensor 🌟 We’re honored to be recognized as Best Skin Cancer Detection Technology Company 2025 – USA by Global Health & Pharma! This recognition reflects our mission to help address two of healthcare’s biggest challenges in skin cancer detection: 1️⃣ The difficulty general practitioners face in identifying skin cancers among millions of lesions. 2️⃣ The long wait times patients endure to see a dermatologist. At DermaSensor, we’re addressing both. 💡 ✔️ Empowering healthcare professionals with data-driven breakthrough technology. ✔️ Enabling real-time lesion assessments in primary care, supporting timely referrals and better outcomes. ✔️ Driving sustained innovation and progress to strengthen frontline healthcare. 👉 Read more about this recognition: https://lnkd.in/eprGeG4k Together, we’re shaping the future of early skin cancer risk assessment. 🌍✨ #GPH #DermaSensor #MedTech #AIinHealthcare #SkinCancerAwareness #Innovation